Our follow-up studies will continue to provide insights into the mechanisms by which GPAT4 regulates platinum resistance in ovarian cancer; we will increase the number of assessed patients with EOC and work to establish a link between SLC7A11 and the regulation of GPAT4. Here, GPAT4 is linked to ovarian cancer.